Novartis Triaminic Allerchews With Loratadine Slated To Launch In 2004
This article was originally published in The Tan Sheet
Executive Summary
Novartis' Triaminic children's cough/coldline will be extended in early 2004 with Allerchews, the brand's first loratadine-containing offering. The product debuted at the National Association of Chain Drug Stores Marketplace in San Diego June 8-10
You may also be interested in...
Novartis OTC Business Makes Net Gains On Loratadine Sales In Q2
Novartis Consumer Healthcare's OTC unit is looking to its loratadine products to continue improving the division's net earnings for the remainder of the year
Novartis OTC Business Makes Net Gains On Loratadine Sales In Q2
Novartis Consumer Healthcare's OTC unit is looking to its loratadine products to continue improving the division's net earnings for the remainder of the year
Novartis OTC Business Makes Net Gains On Loratadine Sales In Q2
Novartis Consumer Healthcare's OTC unit is looking to its loratadine products to continue improving the division's net earnings for the remainder of the year